RIO DE JANEIRO, Brazil – A series of regulatory challenges across Latin America are hindering the development of biotech projects in a region many see as being fertile with potential.
RIO DE JANEIRO – Latin America still doesn’t have biotech clusters, an important tool to boost economic growth and drive research, said industry experts at the BIO Latin American conference recently, adding that, to succeed, the region will have to create the environment and the ecosystem to develop such clusters.
RIO DE JANEIRO – With the participation of about 530 attendees, the second edition of BIO Latin America launched Thursday, bringing together biotech sector stakeholders to discuss opportunities in the sector that may be found and what barriers exist across the region.
BOGOTA, Colombia – Teva Pharmaceutical Industries Ltd. has agreed to acquire Representaciones e Investigaciones Médicas (Rimsa), of Mexico City, in a deal valued at $2.3 billion that will position the Israeli firm as the leading pharmaceutical company in Mexico, the second largest pharma market in Latin America behind Brazil.
BOGOTA, Colombia – The links between the biotech sectors in Latin America and the Middle East and North Africa (MENA) remain shallow, even if industry stakeholders in both sides believe in the potential the relationships represent.
